CHA News Article

Contamination Identified in Additional NECC Medical Products

As part of the ongoing investigation of the fungal meningitis outbreak, the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) reported Nov. 1 that unopened vials of betamethasone and cardioplegia solution distributed and later recalled by the New England Compounding Center (NECC) tested posted for bacterial contamination. The CDC and FDA continue to test medical products from NECC. For more information on the investigation, go to